{"id":1427,"date":"2020-10-08T09:55:43","date_gmt":"2020-10-08T16:55:43","guid":{"rendered":"https:\/\/depts.washington.edu\/pandemicalliance\/?p=1427"},"modified":"2020-10-09T09:57:17","modified_gmt":"2020-10-09T16:57:17","slug":"remdesivir-for-the-treatment-of-covid-19-final-report","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/10\/08\/remdesivir-for-the-treatment-of-covid-19-final-report\/","title":{"rendered":"Remdesivir for the Treatment of Covid-19 &#8211; Final Report"},"content":{"rendered":"<ul>\n<li>Infusion of the antiviral drug remdesivir led to faster recovery time (median 10 vs. 15 days) and a non-significantly lower risk of death at 29 days (HR=0.73, 95% CI 0.52-1.03) in a randomized, placebo-controlled trial among patients hospitalized with COVID-19. Serious adverse events were reported in 131 of 532 (24.6%) patients in the remdesivir group and in 163 of 516 (31.6%) patients in the placebo group. [EDITORIAL NOTE: A preliminary version of this manuscript was summarized in the Lit Rep on May 26, 2020.]<\/li>\n<\/ul>\n<p>Beigel et al. (October 8, 2020). Remdesivir for the Treatment of Covid-19 &#8211; Final Report. The New England Journal of Medicine. <a href=\"https:\/\/doi.org\/10.1056\/NEJMoa2007764\">https:\/\/doi.org\/10.1056\/NEJMoa2007764<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Infusion of the antiviral drug remdesivir led to faster recovery time (median 10 vs. 15 days) and a non-significantly lower risk of death at 29 days (HR=0.73, 95% CI 0.52-1.03) in a randomized, placebo-controlled trial among patients hospitalized with COVID-19. Serious adverse events were reported in 131 of 532 (24.6%) patients in the remdesivir group&#8230;<\/p>\n<div><a class=\"more\" href=\"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/10\/08\/remdesivir-for-the-treatment-of-covid-19-final-report\/\">Read more<\/a><\/div>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[6],"tags":[28],"topic":[19],"class_list":["post-1427","post","type-post","status-publish","format-standard","hentry","category-article-summary","tag-treatment","topic-testing-and-treatment"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/1427","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/comments?post=1427"}],"version-history":[{"count":1,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/1427\/revisions"}],"predecessor-version":[{"id":1428,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/1427\/revisions\/1428"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/media?parent=1427"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/categories?post=1427"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/tags?post=1427"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/topic?post=1427"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}